Analysts at Peel Hunt Kept their Buy rating for U and I Group Plc (LON:UAI) with GBX 230.00 PT; IRADIMED Has 0.42 Sentiment

Iradimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging compatible products, and related accessories and services in the United States and internationally. The company has market cap of $158.33 million. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. It has a 116.28 P/E ratio. The firm also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories; iMagox MRI pulse oximeter; and iMagox MRI oximeter remote and display products.

They currently have a GBX 230.00 PT on U and I Group Plc (LON:UAI). Peel Hunt’s target would suggest a potential upside of 11.25% from the company’s previous stock close. This was revealed to clients and investors in an analyst note on Monday, 5 February.

U and I Group PLC, together with its subsidiaries, invests and trades in, and develops real estate properties in the United Kingdom. The company has market cap of 259.60 million GBP. The firm operates through three divisions: Investment, Development and Trading, and Operating. It has a 49.4 P/E ratio. The Company’s property portfolio includes mixed-use regeneration projects, office buildings, residential units and apartments, retail units, shopping centers, and commercial spaces.

Among 3 analysts covering U And I Group Plc (LON:UAI), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. U And I Group Plc has GBX 300 highest and GBX 200 lowest target. GBX 240’s average target is 15.66% above currents GBX 207.5 stock price. U And I Group Plc had 22 analyst reports since April 12, 2016 according to SRatingsIntel. Peel Hunt maintained U and I Group PLC (LON:UAI) rating on Monday, February 5. Peel Hunt has “Buy” rating and GBX 230 target. The firm has “Buy” rating by Peel Hunt given on Thursday, April 28. The company was maintained on Tuesday, May 16 by Barclays Capital. JP Morgan maintained U and I Group PLC (LON:UAI) on Tuesday, September 6 with “Overweight” rating. The stock of U and I Group PLC (LON:UAI) has “Buy” rating given on Friday, December 22 by Peel Hunt. Peel Hunt maintained it with “Buy” rating and GBX 230 target in Wednesday, April 26 report. The rating was maintained by Peel Hunt with “Buy” on Tuesday, January 10. The company was maintained on Tuesday, August 16 by Peel Hunt. The firm earned “Buy” rating on Wednesday, October 19 by Peel Hunt. The firm earned “Overweight” rating on Friday, April 29 by Barclays Capital.

The stock increased 0.97% or GBX 2 during the last trading session, reaching GBX 207.5. About 26,464 shares traded. U and I Group PLC (LON:UAI) has 0.00% since February 5, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock increased 1.69% or $0.25 during the last trading session, reaching $15. About 10,390 shares traded. IRadimed Corporation (IRMD) has declined 54.40% since February 5, 2017 and is downtrending. It has underperformed by 71.10% the S&P500.